LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 109

Search options

  1. Article ; Online: Adjuvant Docetaxel in Nonmetastatic Prostate Cancer: The King Is Dead, Long Live the King!

    Van den Broeck, Thomas / Joniau, Steven / Everaerts, Wouter

    European urology

    2023  Volume 84, Issue 2, Page(s) 164–165

    MeSH term(s) Male ; Humans ; Docetaxel/therapeutic use ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/pathology ; Adjuvants, Immunologic ; Chronic Disease
    Chemical Substances Docetaxel (15H5577CQD) ; Adjuvants, Immunologic
    Language English
    Publishing date 2023-06-01
    Publishing country Switzerland
    Document type Editorial ; Comment
    ZDB-ID 193790-x
    ISSN 1873-7560 ; 1421-993X ; 0302-2838
    ISSN (online) 1873-7560 ; 1421-993X
    ISSN 0302-2838
    DOI 10.1016/j.eururo.2023.05.033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: "Keep It Short and Simple": Perceptions of patients and healthcare professionals on the use of a mobile health app in the care for patients undergoing radical prostatectomy.

    Clinckaert, Andries / Schreurs, Lucas / Wouters, Lars / Everaerts, Wouter / De Cock, Diederik

    BJUI compass

    2023  Volume 5, Issue 1, Page(s) 150–158

    Abstract: Background: Patients undergoing radical prostatectomy for localised prostate cancer generally have good long-term survival rates. However, late recurrences can occur and require lifelong follow-up.: Objective: This research aims to investigate ... ...

    Abstract Background: Patients undergoing radical prostatectomy for localised prostate cancer generally have good long-term survival rates. However, late recurrences can occur and require lifelong follow-up.
    Objective: This research aims to investigate different stakeholders' perceptions on the use of mobile health (mHealth) applications for prostate cancer follow-up after radical prostatectomy.
    Methods: A cross-sectional qualitative study was conducted to explore stakeholders' perceptions of an mHealth application for follow-up after radical prostatectomy. Urologists, nurses, and patients treated with radical prostatectomy were interviewed, and data were transcribed and analysed using thematic analysis according to Qualitative Analysis Guide of Leuven. Recommended features for an ideal mHealth application were grouped according to the Persuasive Systems Design model.
    Results and limitations: A total of 30 stakeholders, consisting of nurse specialists (
    Conclusions: Stakeholders indicate that an mHealth app in the care for post-prostatectomy patients can improve patient care and promote disease management but consider app compliance as a major challenge.
    Patient summary: We interviewed patients, nurses, and urologists about using an mHealth application for follow-up after radical prostatectomy. The participants agreed that an mHealth app could improve care optimisation and disease management, but some concerns and barriers were expressed. This resulted in a list of recommended features for an ideal app.
    Language English
    Publishing date 2023-07-15
    Publishing country United States
    Document type Journal Article
    ISSN 2688-4526
    ISSN (online) 2688-4526
    DOI 10.1002/bco2.270
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Transient receptor potential channels in sensory mechanisms of the lower urinary tract.

    Vanneste, Matthias / Segal, Andrei / Voets, Thomas / Everaerts, Wouter

    Nature reviews. Urology

    2021  Volume 18, Issue 3, Page(s) 139–159

    Abstract: Disruptions to sensory pathways in the lower urinary tract commonly occur and can give rise to lower urinary tract symptoms (LUTS). The unmet clinical need for treatment of LUTS has stimulated research into the molecular mechanisms that underlie neuronal ...

    Abstract Disruptions to sensory pathways in the lower urinary tract commonly occur and can give rise to lower urinary tract symptoms (LUTS). The unmet clinical need for treatment of LUTS has stimulated research into the molecular mechanisms that underlie neuronal control of the bladder and transient receptor potential (TRP) channels have emerged as key regulators of the sensory processes that regulate bladder function. TRP channels function as molecular sensors in urothelial cells and afferent nerve fibres and can be considered the origin of bladder sensations. TRP channels in the lower urinary tract contribute to the generation of normal and abnormal bladder sensations through a variety of mechanisms, and have demonstrated potential as targets for the treatment of LUTS in functional disorders of the lower urinary tract.
    MeSH term(s) Female ; Humans ; Lower Urinary Tract Symptoms/metabolism ; Lower Urinary Tract Symptoms/physiopathology ; Male ; Muscle, Smooth/innervation ; Muscle, Smooth/metabolism ; Muscle, Smooth/physiopathology ; Prostate/metabolism ; Prostate/physiopathology ; Sensation/physiology ; TRPA1 Cation Channel/metabolism ; TRPM Cation Channels/metabolism ; TRPV Cation Channels/metabolism ; Transient Receptor Potential Channels/metabolism ; Urethra/metabolism ; Urethra/physiopathology ; Urinary Bladder/innervation ; Urinary Bladder/metabolism ; Urinary Bladder/physiopathology ; Urothelium/innervation ; Urothelium/metabolism ; Visceral Afferents/physiopathology
    Chemical Substances TRPA1 Cation Channel ; TRPM Cation Channels ; TRPV Cation Channels ; Transient Receptor Potential Channels
    Language English
    Publishing date 2021-02-03
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2493737-X
    ISSN 1759-4820 ; 1759-4812
    ISSN (online) 1759-4820
    ISSN 1759-4812
    DOI 10.1038/s41585-021-00428-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2 Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004.

    Grivas, Nikolaos / Goonewardene, Sanchia / Everaerts, Wouter / Kalampokis, Nikolaos

    European urology focus

    2020  Volume 7, Issue 5, Page(s) 1210–1211

    MeSH term(s) Humans ; Kidney Neoplasms/surgery ; Medical Oncology ; Nephrectomy ; Prospective Studies
    Language English
    Publishing date 2020-12-24
    Publishing country Netherlands
    Document type Letter ; Comment
    ISSN 2405-4569
    ISSN (online) 2405-4569
    DOI 10.1016/j.euf.2020.11.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: TRiPping down the oesophagus.

    Everaerts, Wouter

    The Journal of physiology

    2011  Volume 589, Issue Pt 14, Page(s) 3415–3416

    MeSH term(s) Adenosine Triphosphate/metabolism ; Animals ; Calcium/metabolism ; Esophagus/metabolism ; Keratinocytes/metabolism ; Male ; TRPV Cation Channels/metabolism
    Chemical Substances TRPV Cation Channels ; Trpv4 protein, mouse ; Adenosine Triphosphate (8L70Q75FXE) ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2011-07-14
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 3115-x
    ISSN 1469-7793 ; 0022-3751
    ISSN (online) 1469-7793
    ISSN 0022-3751
    DOI 10.1113/jphysiol.2011.212977
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Double trouble for prostate cancer: synergistic action of AR blockade and PARPi in non-HRR mutated patients.

    Giesen, Alexander / Baekelandt, Loïc / Devlies, Wout / Devos, Gaëtan / Dumez, Herlinde / Everaerts, Wouter / Claessens, Frank / Joniau, Steven

    Frontiers in oncology

    2023  Volume 13, Page(s) 1265812

    Abstract: Prostate cancer (PCa) is the most common cancer in men worldwide. Despite better and more intensive treatment options in earlier disease stages, a large subset of patients still progress to metastatic castration-resistant PCa (mCRPC). Recently, poly-(ADP- ...

    Abstract Prostate cancer (PCa) is the most common cancer in men worldwide. Despite better and more intensive treatment options in earlier disease stages, a large subset of patients still progress to metastatic castration-resistant PCa (mCRPC). Recently, poly-(ADP-ribose)-polymerase (PARP)-inhibitors have been introduced in this setting. The TALAPRO-2 and PROpel trials both showed a marked benefit of PARPi in combination with an androgen receptor signaling inhibitor (ARSI), compared with an ARSI alone in both the homologous recombination repair (HRR)-mutated, as well as in the HRR-non-mutated subgroup. In this review, we present a comprehensive overview of how maximal AR-blockade via an ARSI in combination with a PARPi has a synergistic effect at the molecular level, leading to synthetic lethality in both HRR-mutated and HRR-non-mutated PCa patients. PARP2 is known to be a cofactor of the AR complex, needed for decompacting the chromatin and start of transcription of AR target genes (including HRR genes). The inhibition of PARP thus reinforces the effect of an ARSI. The deep androgen deprivation caused by combining androgen deprivation therapy (ADT) with an ARSI, induces an HRR-like deficient state, often referred to as "BRCA-ness". Further, PARPi will prevent the repair of single-strand DNA breaks, leading to the accumulation of DNA double-strand breaks (DSBs). Due to the induced HRR-deficient state, DSBs cannot be repaired, leading to apoptosis.
    Language English
    Publishing date 2023-09-21
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2649216-7
    ISSN 2234-943X
    ISSN 2234-943X
    DOI 10.3389/fonc.2023.1265812
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Machine learning-assisted fluoroscopy of bladder function in awake mice.

    De Bruyn, Helene / Corthout, Nikky / Munck, Sebastian / Everaerts, Wouter / Voets, Thomas

    eLife

    2022  Volume 11

    Abstract: Understanding the lower urinary tract (LUT) and development of highly needed novel therapies to treat LUT disorders depends on accurate techniques to monitor LUT (dys)function in preclinical models. We recently developed videocystometry in rodents, which ...

    Abstract Understanding the lower urinary tract (LUT) and development of highly needed novel therapies to treat LUT disorders depends on accurate techniques to monitor LUT (dys)function in preclinical models. We recently developed videocystometry in rodents, which combines intravesical pressure measurements with X-ray-based fluoroscopy of the LUT, allowing the in vivo analysis of the process of urine storage and voiding with unprecedented detail. Videocystometry relies on the precise contrast-based determination of the bladder volume at high temporal resolution, which can readily be achieved in anesthetized or otherwise motion-restricted mice but not in awake and freely moving animals. To overcome this limitation, we developed a machine-learning method, in which we trained a neural network to automatically detect the bladder in fluoroscopic images, allowing the automatic analysis of bladder filling and voiding cycles based on large sets of time-lapse fluoroscopic images (>3 hr at 30 images/s) from behaving mice and in a noninvasive manner. With this approach, we found that urethane, an injectable anesthetic that is commonly used in preclinical urological research, has a profound, dose-dependent effect on urethral relaxation and voiding duration. Moreover, both in awake and in anesthetized mice, the bladder capacity was decreased ~fourfold when cystometry was performed acutely after surgical implantation of a suprapubic catheter. Our findings provide a paradigm for the noninvasive, in vivo monitoring of a hollow organ in behaving animals and pinpoint important limitations of the current gold standard techniques to study the LUT in mice.
    MeSH term(s) Animals ; Fluoroscopy ; Machine Learning ; Mice ; Urethane ; Urinary Bladder/diagnostic imaging ; Urodynamics ; Wakefulness
    Chemical Substances Urethane (3IN71E75Z5)
    Language English
    Publishing date 2022-09-06
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2687154-3
    ISSN 2050-084X ; 2050-084X
    ISSN (online) 2050-084X
    ISSN 2050-084X
    DOI 10.7554/eLife.79378
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Inhibition of TRPM8 by the urinary tract analgesic drug phenazopyridine.

    Luyts, Noémie / Daniluk, Jan / Freitas, Ana Cristina Nogueira / Bazeli, Bahar / Janssens, Annelies / Mulier, Marie / Everaerts, Wouter / Voets, Thomas

    European journal of pharmacology

    2023  Volume 942, Page(s) 175512

    Abstract: Background: and purpose: Phenazopyridine (PAP) is an over-the-counter drug widely used to provide symptomatic relief of bladder pain in conditions such as cystitis or bladder pain syndrome (BPS). Whereas the analgesic effect of PAP has been attributed ... ...

    Abstract Background: and purpose: Phenazopyridine (PAP) is an over-the-counter drug widely used to provide symptomatic relief of bladder pain in conditions such as cystitis or bladder pain syndrome (BPS). Whereas the analgesic effect of PAP has been attributed to a local effect on the mucosa of the lower urinary tract (LUT), the molecular targets of PAP remain unknown. We investigated the effect of PAP on pain-related Transient Receptor Potential (TRP) channels expressed in sensory neurons that innervate the bladder wall.
    Experimental approach: The effects of PAP on the relevant TRP channels (TRPV1, TRPA1, TRPM8, TRPM3) expressed in HEK293 or CHO cells was investigated using Fura-2-based calcium measurements and whole-cell patch-clamp recordings. Activity of PAP on TRPM8 was further analysed using Fura-2-based calcium imaging on sensory neurons isolated from lumbosacral dorsal root ganglia (DRG) of mice.
    Key results: PAP rapidly and reversibly inhibits responses of TRPM8 expressed in HEK293 cells to cold and menthol, with IC
    Conclusion and implications: PAP inhibits TRPM8 in a concentration range consistent with PAP levels in the urine of treated patients. Since TRPM8 is expressed in bladder afferent neurons and upregulated in patients with painful bladder disorders, TRPM8 inhibition may underlie the analgesic activity of PAP.
    MeSH term(s) Animals ; Cricetinae ; Humans ; Mice ; Calcium/metabolism ; Cricetulus ; Fura-2/pharmacology ; Ganglia, Spinal/metabolism ; HEK293 Cells ; Menthol/pharmacology ; Pain ; Phenazopyridine/pharmacology ; Sensory Receptor Cells/metabolism ; Transient Receptor Potential Channels ; TRPA1 Cation Channel ; TRPM Cation Channels ; Urinary Bladder/metabolism
    Chemical Substances Calcium (SY7Q814VUP) ; Fura-2 (TSN3DL106G) ; Menthol (1490-04-6) ; Phenazopyridine (K2J09EMJ52) ; Transient Receptor Potential Channels ; TRPA1 Cation Channel ; TRPM Cation Channels ; TRPM3 protein, mouse ; TRPM8 channel-associated factor 1 protein, human ; TRPM8 protein, human ; TRPM8 protein, mouse
    Language English
    Publishing date 2023-01-16
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 80121-5
    ISSN 1879-0712 ; 0014-2999
    ISSN (online) 1879-0712
    ISSN 0014-2999
    DOI 10.1016/j.ejphar.2023.175512
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: TRPM8 antagonists to treat lower urinary tract symptoms: don't lose your cool just yet.

    Everaerts, Wouter / De Ridder, Dirk

    BJU international

    2016  Volume 117, Issue 3, Page(s) 384–385

    MeSH term(s) Afferent Pathways/physiology ; Animals ; Female ; TRPM Cation Channels/physiology ; Urinary Bladder/physiology
    Chemical Substances TRPM Cation Channels
    Language English
    Publishing date 2016-03
    Publishing country England
    Document type Comment ; Editorial
    ZDB-ID 1462191-5
    ISSN 1464-410X ; 1464-4096 ; 1358-8672
    ISSN (online) 1464-410X
    ISSN 1464-4096 ; 1358-8672
    DOI 10.1111/bju.13321
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: The Prevalence of Lower Limb and Genital Lymphedema after Prostate Cancer Treatment: A Systematic Review.

    Clinckaert, Andries / Callens, Klaas / Cooreman, Anne / Bijnens, Annabel / Moris, Lisa / Van Calster, Charlotte / Geraerts, Inge / Joniau, Steven / Everaerts, Wouter

    Cancers

    2022  Volume 14, Issue 22

    Abstract: 1) Background: Secondary lymphedema is a chronic, progressive, and debilitating condition with an important impact on quality of life. Lymphedema is a frequently reported complication in oncological surgery but has not been systematically studied in the ...

    Abstract (1) Background: Secondary lymphedema is a chronic, progressive, and debilitating condition with an important impact on quality of life. Lymphedema is a frequently reported complication in oncological surgery but has not been systematically studied in the setting of prostate cancer. (2) Methods: Pubmed/MEDLINE and Embase were systematically searched to identify articles reporting on lower limb or genital lymphedema after primary treatment (surgery of radiation therapy) of the prostate and the pelvic lymph nodes in men with prostate cancer. Primary outcome was the prevalence of lower limb and genital lymphedema. (3) Results: Eighteen articles were eligible for qualitative synthesis. Risk of bias was high in all included studies, with only one study providing a prespecified definition of secondary lymphedema. Eleven studies report the prevalence of lower limb (0-14%) and genital (0-1%) lymphedema after radical prostatectomy with pelvic lymph node dissection (PLND) Seven studies report a low prevalence of lower limb (0-9%) and genital (0-8%) lymphedema after irradiation of the pelvic lymph nodes. However, in the patient subgroups that underwent pelvic irradiation after staging pelvic lymph node dissections, the prevalence of lower limb (18-29%) and genital (2-22%) lymphedema is substantially elevated. (4) Conclusion: Prostate cancer patients undergoing surgery or irradiation of the pelvic lymph nodes are at risk of developing secondary lymphedema in the lower limbs and the genital region. Patients receiving pelvic radiation after pelvic lymph node dissection have the highest prevalence of lymphedema. The lack of a uniform definition and standardized diagnostic criteria for lower limb and genital lymphedema hampers the accurate estimation of their true prevalence. Future clinicals trials are needed to specifically evaluate secondary lymphedema in patients undergoing prostate cancer treatments, to identify potential risk factors and to determine the impact on quality of life.
    Language English
    Publishing date 2022-11-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers14225667
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top